» Articles » PMID: 7465604

Blockade of Endogenous Opiates Reduces Activity in the Rat

Overview
Publisher Elsevier
Date 1981 Jan 1
PMID 7465604
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Naloxone (2 mg/kg, SC) was found to result in a substantial and significant reduction in general activity levels in the rat (90--120 days old). This effect was seen both under baseline conditions and after stress manipulations which would be expected to result in elevated levels of endogenous opiate peptides. Thus, under baseline conditions general activity was reduced to less than half of the saline control value thirty min after injection. Similarly, a reduction was seen after stress induced by a 30 min swim. While naloxone may have some non-opiate effects, these results support the view that endogenous opiate systems may play an important activational role in behavioral regulation, under baseline conditions and conditions of stress.

Citing Articles

Opioid blockade attenuates acquisition and expression of cocaine-induced place preference conditioning in rats.

Gerrits M, Patkina N, Zvartau E, van Ree J Psychopharmacology (Berl). 1995; 119(1):92-8.

PMID: 7675956 DOI: 10.1007/BF02246059.


Acute effects of naloxone and naltrexone, but lack of delayed effects, on exploratory behavior in the rat.

Koek W, Slangen J Psychopharmacology (Berl). 1984; 84(3):383-7.

PMID: 6440184 DOI: 10.1007/BF00555217.


Influence of naloxone on antidepressant drug effects in the forced swimming test in mice.

Devoize J, Rigal F, Eschalier A, Trolese J, Renoux M Psychopharmacology (Berl). 1984; 84(1):71-5.

PMID: 6436893 DOI: 10.1007/BF00432028.


Interactions between naloxone and GABA in the control of locomotor activity in the rat.

Agmo A, Tarasco C J Neural Transm. 1985; 61(3-4):137-49.

PMID: 2985744 DOI: 10.1007/BF01251908.


Comparison of the behavioural effects induced by administration in rat nucleus accumbens or nucleus caudatus of selective mu and delta opioid peptides or kelatorphan an inhibitor of enkephalin-degrading-enzymes.

Dauge V, Rossignol P, Roques B Psychopharmacology (Berl). 1988; 96(3):343-52.

PMID: 2851851 DOI: 10.1007/BF00216060.